3718 Federal Register / Vol. 65, No. 15 / Monday, January 24, 2000 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substance and

Disease Registry

Public Meeting of the Inter-tribal

Council on Hanford Health Projects

(ICHHP) in Association With the

Citizens Advisory Committee on Public

Health Service (PHS) Activities and

Research at Department of Energy

(DOE) Sites: Hanford Health Effects

Subcommittee

Name: Public meeting of the Inter-tribal

Council on Hanford Health Projects (ICHHP)

in association with the Citizens Advisory

Committee on PHS Activities and Research at

DOE Sites: Hanford Health Effects

Subcommittee (HHES).

Time and Date: 9 a.m.–4 p.m., February 9,

2000.

Place: DoubleTree Hotel Portland—

Downtown, 310 S.W. Lincoln, Portland,

Oregon 97201, telephone: (503) 221–0450.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Background: Under a Memorandum of

Understanding (MOU) signed in October

1990 and renewed in November 1992

between ATSDR and DOE. The MOU

delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental Response,

Compensation, and Liability Act (CERCLA or

‘‘Superfund’’). These activities include health

consultations and public health assessments

at DOE sites listed on, or proposed for, the

Superfund National Priorities List and at

sites that are the subject of petitions from the

public; and other health-related activities

such as epidemiologic studies, health

surveillance, exposure and disease registries,

health education, substance-specific applied

research, emergency response, and

preparation of toxicological profiles.

In addition, under an MOU signed in

December 1990 with DOE and replaced by an

MOU signed in 1996, the Department of

Health and Human Services (HHS) has been

given the responsibility and resources for

conducting analytic epidemiologic

investigations of residents of communities in

the vicinity of DOE facilities, workers at DOE

facilities, and other persons potentially

exposed to radiation or to potential hazards

from non-nuclear energy production and use.

HHS has delegated program responsibility to

CDC. Community Involvement is a critical

part of ATSDR’s and CDC’s energy-related

research and activities and input from

members of the ICHHP is part of these efforts.

The ICHHP will work with the HHES to

provide input on American Indian health

effects at the Hanford, Washington site.

Purpose: The purpose of this meeting is to

address issues that are unique to tribal

involvement with the HHES, including a

presentation and discussion on the DOE

Richland Indian Office, update on tribal

cooperative agreements, and agency updates.

Matters To Be Discussed: Agenda items

will include a dialogue on issues that are

unique to tribal involvement with the HHES.

This will include updating tribal members of

the cooperative agreement activities in

environmental health capacity building and

providing support for tribal involvement in

and representation on the HHES.

Agenda items are subject to change as

priorities dictate.

Contact Persons For More Information:

Leslie C. Campbell, Executive Secretary

HHES, Division of Health Assessment and

Consultation, ATSDR, 1600 Clifton Road, NE

M/S E–32, Atlanta, Georgia 30333, telephone

1–888/42–ATSDR (28737), fax 404/639–0654.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: January 18, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–1591 Filed 1–21–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substance and

Disease Registry

Citizens Advisory Committee on Public

Health Service (PHS) Activities and

Research at Department of Energy

(DOE) Sites: Hanford Health Effects

Subcommittee

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Agency for Toxic

Substances and Disease Registry

(ATSDR) and the Centers for Disease

Control and Prevention (CDC) announce

the following meeting.

Name: Citizens Advisory Committee

on PHS Activities and Research at DOE

Sites: Hanford Health Effects

Subcommittee (HHES).

Times and Dates: 8:30 a.m.–5:30 p.m.,

February 10, 2000. 8 a.m.–4 p.m.,

February 11, 2000.

Place: DoubleTree Hotel Portland—

Downtown, 310 S.W. Lincoln, Portland,

Oregon 97201, telephone: (503) 221–

0450.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 100

people.

Background: Under a Memorandum

of Understanding (MOU) signed in

October 1990 and renewed in November

1992 between ATSDR and DOE. The

MOU delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA or ‘‘Superfund’’). These

activities include health consultations

and public health assessments at DOE

sites listed on, or proposed for, the

Superfund National Priorities List and

at sites that are the subject of petitions

from the public; and other healthrelated activities such as epidemiologic

studies, health surveillance, exposure

and disease registries, health education,

substance-specific applied research,

emergency response, and preparation of

toxicological profiles. In addition, under

an MOU signed in December 1990 with

DOE and replaced by an MOU signed in

1996, the Department of Health and

Human Services (HHS) has been given

the responsibility and resources for

conducting analytic epidemiologic

investigations of residents of

communities in the vicinity of DOE

facilities, workers at DOE facilities, and

other persons potentially exposed to

radiation or to potential hazards from

non-nuclear energy production and use.

HHS has delegated program

responsibility to CDC.

Purpose: This subcommittee is

charged with providing advice and

recommendations to the Director, CDC,

and the Administrator, ATSDR,

regarding community, American Indian

Tribes, and labor concerns pertaining to

CDC’s and ATSDR’s public health

activities and research at this DOE site.

The purpose of this meeting is to receive

an update from the Inter-tribal Council

on Hanford Health Projects; to review

and approve the Minutes of the previous

meeting; to receive updates from

ATSDR/NCEH and NIOSH; to receive

reports from the Outreach, Public

Health Assessment, Public Health

Activities, and the Studies Workgroups;

and to address other issues and topics,

as necessary.

Matters To Be Discussed: Agenda

items include a continuing discussion

on the health effects subcommittee

evaluation, update on the membership

selection process, and Public health

assessments and reports. Agenda items

are subject to change as priorities

dictate.

Contact Persons for More Information:

Leslie C. Campbell, Executive Secretary

HHES, Division of Health Assessment

and Consultation, ATSDR, 1600 Clifton

Road, NE M/S E–32, Atlanta, Georgia

30333, telephone 1–888/42–

ATSDR(28737), fax 404/639–0654.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

Federal Register / Vol. 65, No. 15 / Monday, January 24, 2000 / Notices 3719

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: January 18, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–1590 Filed 1–21–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 98N–0144]

Agency Information Collection

Activities; Announcement of OMB

Approval; Biological Products

Regulated Under Section 351 of the

Public Health Service Act;

Implementation of Biologics License;

Elimination of Establishment License

and Product License

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Biological Products Regulated Under

Section 351 of the Public Health Service

Act; Implementation of Biologics

License; Elimination of Establishment

License and Product License’’ has been

approved by the Office of Management

and Budget (OMB) under the Paperwork

Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

JonnaLynn P. Capezzuto, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–4659.

SUPPLEMENTARY INFORMATION: In the

Federal Register of October 20, 1999 (64

FR 56441), the agency announced that

the proposed information collection had

been submitted to OMB for review and

clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0427. The

approval expires on December 31, 2002.

A copy of the supporting statement for

this information collection is available

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: January 14, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 00–1537 Filed 1–21–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 99N–2549]

Agency Information Collection

Activities; Announcement of OMB

Approval; Cosmetic Product Voluntary

Reporting Program

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Cosmetic Product Voluntary Reporting

Program’’ has been approved by the

Office of Management and Budget

(OMB) under the Paperwork Reduction

Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Peggy Schlosburg, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1223.

SUPPLEMENTARY INFORMATION: In the

Federal Register of October 28, 1999 (64

FR 58069), the agency announced that

the proposed information collection had

been submitted to OMB for review and

clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0030. The

approval expires on December 31, 2002.

A copy of the supporting statement for

this information collection is available

on the Internet at http://www.fda.gov/

ohrms/dockets.

Dated: January 14, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 00–1538 Filed 1–21–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00F–0175]

Cultor Food Science, Inc., DSM Food

Specialties, and Protein Technologies

International; Filing of Food Additive

Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Cultor Food Science, Inc., DSM

Food Specialties, and Protein

Technologies International have filed a

petition proposing that the food additive

regulations be amended regarding the

safe use of natamycin on cheese.

FOR FURTHER INFORMATION CONTACT:

Felicia Binion Williams, Center for Food

Safety and Applied Nutrition (HFS–

206), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3122.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 0A4704) has been filed by

Cultor Food Science, Inc., 430 Saw Mill

River Rd., Ardsley, NY 10502; DSM

Food Specialties, 700 American Ave.,

suite 300, King of Prussia, PA 19406;

and Protein Technologies International,

Checkerboard Square, St. Louis, MO

63164. The petition proposes that the

food additive regulations in 21 CFR

172.155 Natamycin (pimaricin) be

amended by listing only the use level of

natamycin permitted in cheese and by

eliminating the reference for the method

of application.

The agency has determined under 21

CFR 25.32(k) that this action is of a type

that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

Dated: January 4, 2000.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 00–1541 Filed 1–21–00; 8:45 am]

BILLING CODE 4160–01–F